Coolrail Linear Pen

K183065 · AtriCure, Inc. · OCL · Dec 4, 2018 · General, Plastic Surgery

Device Facts

• Record ID: K183065
• Device Name: Coolrail Linear Pen
• Applicant: AtriCure, Inc.
• Product Code: OCL · General, Plastic Surgery
• Decision Date: Dec 4, 2018
• Decision: SESE
• Submission Type: Special
• Regulation: 21 CFR 878.4400
• Device Class: Class 2
• Attributes: Therapeutic

Intended Use

The Coolrail® linear pen is a sterile, single use electrosurgery device intended to ablate cardiac tissue during cardiac surgery using radiofrequency (RF) energy.

Device Story

Hand-held, single-use electrosurgical pen; used during cardiac surgery by physicians. Device utilizes bipolar radiofrequency (RF) energy generated by external AtriCure Ablation and Sensing Unit (ASU). Energy delivery controlled via footswitch and passive source switch (AtriCure Switch Matrix). Features internally cooled electrodes to reduce thermal heating, facilitating deeper, consistent tissue ablation. Output is thermal ablation of cardiac tissue. Modification from predicate includes increased rigidity of shaft's rigid zone using aluminum alloy stiffener.

Clinical Evidence

Bench testing only. Mechanical design verification, reliability testing, thermistor testing, and mechanical testing performed to demonstrate conformance to design controls and specifications. Results met predetermined acceptance criteria.

Technological Characteristics

Bipolar RF electrosurgical device; internally cooled electrodes. Shaft includes aluminum alloy stiffener (non-patient contacting) bonded with epoxy. Sterilization: EtO. Connectivity: connects to external AtriCure ASU and Switch Matrix. Dimensions: 30 mm ablating element, 10.0 inch minimum functional shaft length.

Indications for Use

Indicated for ablation of cardiac tissue during cardiac surgery. Contraindicated for contraceptive tubal coagulation (permanent female sterilization).

Regulatory Classification

Identification

An electrosurgical cutting and coagulation device and accessories is a device intended to remove tissue and control bleeding by use of high-frequency electrical current.

Predicate Devices

• Coolrail linear pen (MCR1) (K122611)

Submission Summary (Full Text)

{0}------------------------------------------------

Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which consists of the letters "FDA" in a blue square, followed by the words "U.S. FOOD & DRUG" in blue, and the word "ADMINISTRATION" in a smaller font size below that.

December 4, 2018

AtriCure, Inc. Caitlin Wunderlin Regulatory Affairs Specialist 7555 Innovation Way Mason, Ohio 45040

Re: K183065

Trade/Device Name: Coolrail Linear Pen (MCR1) Regulation Number: 21 CFR 878.4400 Regulation Name: Electrosurgical Cutting and Coagulation Device and Accessories Regulatory Class: Class II Product Code: OCL Dated: October 24, 2018 Received: November 5, 2018

Dear Caitlin Wunderlin:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for

{1}------------------------------------------------

devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/CombinationProducts/GuidanceRegulatoryInformation/ucm597488.html; good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm.

For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/) and CDRH Learn (http://www.fda.gov/Training/CDRHLearn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (http://www.fda.gov/DICE) for more information or contact DICE by email ([e-mail]) or phone [phone] or 301-796-7100).

Sincerely,

Minde Jellman
for

Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

# Indications for Use

510(k) Number (if known) K183065

Device Name Coolrail Linear Pen (MCR1)

Indications for Use (Describe)

The Coolrail linear pen is a sterile, single use electrosurgery device intended to ablate cardiac surgery using radiofrequency (RF) energy.

| Type of Use (Select one or both, as applicable) | |
|-------------------------------------------------|--|
|-------------------------------------------------|--|

X Prescription Use (Part 21 CFR 801 Subpart D)

| Over-The-Counter Use (21 CFR 801 Subpart C)

## CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

## *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.*

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

> Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff [e-mail]

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

{3}------------------------------------------------

Image /page/3/Picture/0 description: The image shows the AtriCure logo. The logo is in blue and orange. The word "Atri" is in blue, and the word "Cure" is in orange. There is a blue dot above the "i" in "AtriCure". There is a registered trademark symbol next to the "e" in "Cure".

# 510(k) Summary

### l. Applicant Information

| Manufacturer: | AtriCure®, Inc.<br>7555 Innovation Way<br>Mason, Ohio 45040<br>P: 513-755-4100 |
|--------------------|--------------------------------------------------------------------------------|
| Contact Person: | Caitlin Wunderlin<br>Regulatory Affairs Specialist |
| Alternate Contact: | Jonathan McElwee<br>Manager, Regulatory Affairs |
| Date Prepared: | 23 October 2018 |

### . Device Information

| Proprietary Name: | Coolrail® Linear Pen (MCR1) |
|-------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Common Name: | Electrosurgical device |
| Classification: | Surgical device for cutting, coagulation, and/or ablation of tissue including cardiac tissue<br>Regulatory Class: Class II; per 21 CFR 878.4400<br>Product Code: OCL<br>Classification Panel: Cardiovascular |
| Predicate Device: | Coolrail linear pen (MCR1)<br>(K122611, 26 September 2012) |

### III. Device Description

The AtriCure Coolrail Linear Pen (MCR1) is a hand held, single use surgical instrument intended for the ablation of cardiac tissues during cardiac surgery. The pen utilizes bipolar energy generated by the AtriCure Ablation and Sensing Unit (ASU) and is used with the AtriCure Switch Matrix (ASB3), a passive source switch, and footswitch. The Coolrail linear pen is designed with internally cooled electrodes to reduce thermal heating allowing for the energy to traverse deeper and more consistently into the target tissue. The ASU delivers bipolar radiofrequency (RF) energy, which flows between the internally cooled electrodes of the Coolrail linear pen. The Operator controls the application of energy by pressing the footswitch.

{4}------------------------------------------------

### IV. Intended Use/ Indications for Use

The Coolrail® linear pen is a sterile, single use electrosurgery device intended to ablate cardiac tissue during cardiac surgery using radiofrequency (RF) energy.

### Comparison of Technological Characteristics (MCR1 K122611) V.

- The devices include the same intended use, and; ●
- . No changes were made in operating principle, or specifications of performance, and;
- The contraindications, warnings, and precautions remain the same for both the proposed . and predicate, and;
- The devices are applied to the tissue in the same manner with the same method of ablation, and;
- The results of the verification and validation testing:
- o Demonstrated equivalency in performance
- Did not raise any new issues of safety o

Modifications included in the Coolrail linear pen were to increase the rigidity of the rigid zone of the shaft.

| | MCR1 (Predicate) | MCR1 (Subject) |
|-----------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Market Product Name | Coolrail Linear Pen | Coolrail Linear Pen |
| 510(k) Number | K122611 | Subject of this submission (K183065) |
| Intended Use | The Coolrail® linear pen is a sterile, single use electrosurgery device intended to ablate cardiac tissue during cardiac surgery using radiofrequency (RF) energy. | The Coolrail® linear pen is a sterile, single use electrosurgery device intended to ablate cardiac tissue during cardiac surgery using radiofrequency (RF) energy. |
| Contraindication | The device is not intended for contraceptive tubal coagulation (permanent female sterilization). | The device is not intended for contraceptive tubal coagulation (permanent female sterilization). |
| Method of Energy Activation | Footswitch | Footswitch |
| Energy Source | Bipolar radiofrequency energy is generated by the Ablation and Sensing Unit that is sold separately. | Bipolar radiofrequency energy is generated by the Ablation and Sensing Unit that is sold separately. |
| Ablating Element Length | 30 mm | 30 mm |
| Functional Shaft Length | 10.0 inches minimum | 10.0 inches minimum |
| Shaft - Outer Stiffener Length | 7.5 inches minimum | Lengthened by 0.5 inches |
| Shaft - Outer Stiffener Material (Non-patient contacting) | Nylon | Aluminum Alloy |

{5}------------------------------------------------

| Outer Stiffener to Shaft Bonding Agent (Non-patient contacting) | Cyanoacrylate | Epoxy |
|-----------------------------------------------------------------|----------------------------------------|----------------------------------------|
| Packaging | Sterile – Single use disposable device | Sterile – Single use disposable device |
| Sterilization | EtO | EtO |

### VI. Performance Data

Mechanical design verification testing was completed per AtriCure's Quality System to verify the device's conformance to appropriate design controls and specifications to demonstrate equivalence to the previously cleared Coolrail linear pen device. The Coolrail linear pen device met the predetermined acceptance criteria ensuring substantial equivalence to the previously cleared K122611 MCR1 device. No new safety or performance issues were raising during testing.

## Non-clinical Bench Testing:

- Reliability Testing ●
- . Thermistor Testing
- Mechanical testing .

### VII. Conclusions

AtriCure has demonstrated that the Coolrail linear pen is substantially equivalent in fundamental design, technology, function, device materials, packaging, sterilization, operating principal, and intended use/ indication for use as the previously cleared Coolrail linear pen device via K122611 on 26 September 2012.